`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`MYLAN INSTITUTIONAL LLC and PFIZER INC.,
`Petitioners,
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner.
`______________
`
`IPR2020-003241
`Patent 8,114,833
`______________
`
`
`NOTICE OF STIPULATION TO CHANGE DUE DATE 3
`
`
`
`1 IPR2020-01252 has been joined with this proceeding.
`
`
`
`
`
`
`
`
`
`IPR2020-00324
`Patent 8,114,833
`
`Patent Owner Novo Nordisk A/S (“Novo Nordisk”) hereby notifies the Board
`
`that Novo Nordisk and Petitioners Mylan Institutional LLC and Pfizer Inc. have
`
`stipulated to change the deadline of DUE DATE 3 in the Scheduling Order (Paper
`
`15) as provided in the table below:
`
`Due Date
`
`DUE DATE 3
`
`Original Date
`
`Stipulated Date
`
`January 22, 2021
`
`January 29, 2021
`
`Patent Owner’s sur-reply to reply
`
`
`
`
`All other DUE DATES in the Scheduling Order remain the same as indicated
`
`in the Scheduling Order.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1
`
`
`
`Dated: December 18, 2020
`
`
`
`
`
`
`
`
`
`IPR2020-00324
`Patent 8,114,833
`
`Respectfully submitted,
`
`/Jeffrey J. Oelke/ (Electronically signed)
`Jeffrey J. Oelke, Reg. No. 37,409
`Lead Counsel
`
`Ryan P. Johnson
`Laura T. Moran
`Back-Up Counsel
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`(212) 430-2600
`joelke@fenwick.com
`ryan.johnson@fenwick.com
`laura.moran@fenwick.com
`
`Counsel for Patent Owner Novo Nordisk A/S
`
`
`
`-2-
`
`
`
`
`
`IPR2020-00324
`Patent 8,114,833
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on December 18, 2020, the
`
`foregoing document is being served by filing this document through the Patent Trial and
`
`Appeal Board End to End System, as well as by delivering a copy via electronic mail
`
`upon the following counsel of record for Petitioners:
`
`Brandon M. White (Reg. No. 52,354)
`Perkins Coie LLP
`700 Thirteenth Street, N.W., Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6206
`White-ptab@perkinscoie.com
`
`
`
`Lara Dueppen (Reg. No. 65,002)
`Perkins Coie LLP
`1888 Century Park East
`Suite 1700
`Los Angeles, CA 90067
`Telephone: (310) 788-3349
`Dueppen-ptab@perkinscoie.com
`Liraglutide@perkinscoie.com
`
`Emily J. Greb (Reg. No. 68,244)
`Perkins Coie LLP
`33 East Main Street, Suite 201
`Madison, WI 53703
`Greb-ptab@perkinscoie.com
`Tel: (608) 663-7494
`Fax: (608) 283-4494
`
`Jovial Wong (Reg. No. 60,115)
`Charles B. Klein
`Sharon Lin
`Winston & Strawn LLP
`1901 L St. NW
`Washington, DC 20036
`jwong@winston.com
`
`-3-
`
`
`
`cklein@wintson.com
`slin@winston.com
`Tel: (202) 282-5000
`Fax: (202) 282-5100
`
`
`
`Date: December 18, 2020
`
`
`
`
`IPR2020-00324
`Patent 8,114,833
`
`
`
`Respectfully submitted,
`
`/Jeffrey J. Oelke/ (Electronically signed)
`Jeffrey J. Oelke, Reg. No. 37,409
`Lead Counsel
`
`-4-
`
`